Cancer Stem Cells: Biology and Therapeutic Implications. Review uri icon

Overview

abstract

  • It is well recognized that most cancers derive and progress from transformation and clonal expansion of a single cell that possesses stem cell properties, i.e., self-renewal and multilineage differentiation capacities. Such cancer stem cells (CSCs) are usually present at very low frequencies and possess properties that make them key players in tumor development. Indeed, besides having the ability to initiate tumor growth, CSCs drive tumor progression and metastatic dissemination, are resistant to most cancer drugs, and are responsible for cancer relapse. All of these features make CSCs attractive targets for the development of more effective oncologic treatments. In the present review article, we have summarized recent advances in the biology of CSCs, including their identification through their immunophenotype, and their physiology, both in vivo and in vitro. We have also analyzed some molecular markers that might become targets for developing new therapies aiming at hampering CSCs regeneration and cancer relapse.

publication date

  • November 30, 2022

Research

keywords

  • Antineoplastic Agents
  • Neoplasms

Identity

Scopus Document Identifier

  • 85143917707

Digital Object Identifier (DOI)

  • 10.1016/j.arcmed.2022.11.012

PubMed ID

  • 36462951

Additional Document Info

volume

  • 53

issue

  • 8